sprite-preloader
Anzeige
Mehr »
Sonntag, 18.02.2018 Börsentäglich über 12.000 News von 579 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrCancer Research UK announces £45m investment in clinical trials
FrFDA grants orphan drug designation to Selumetinib for neurofibromatosis type 1
FrGSK's Fluarix Tetra wins European approval for expanded indication
FrRoche to buy oncology software provider Flatiron Health for $1.9bn
DoVeloxis secures $60m capital from Athyrium Capital
DoAstellas Pharma acquires Universal Cells for $102m
DoJanssen's Erleada wins FDA nod for nonmetastatic prostate cancer
MiLilly's radiographic axial spondyloarthritis treatment Taltz succeeds in phase 3 study
MiBill Gates foundation awards grants to mRNA vaccine developer CureVac
MiNovartis secures FDA approval for larger dosage of MS drug Glatopa
DiUK's NICE recommends Eusa Pharma's Fotivda to treat advanced renal cell carcinoma
DiDiurnal Group completes patient enrolment in Chronocort's trial for congenital adrenal hyperplasia
DiHorizon Discovery out-licenses cell line engineering technology to US firm
DiVertex's Symdeko cystic fibrosis drug secures FDA approval
MoRoivant, Poxel to develop and commercialise imeglimin in US, Europe and additional countries
MoSeattle Genetics, Pieris enter into $1.2bn immuno-oncology collaboration
MoNovo Nordisk's Ozempic secures European approval for type 2 diabetes
MoApalutamide delays spread of several prostate cancers in phase 3 trial
09.02.Rexahn Pharmaceuticals, Zhejiang Haichang Biotechnology to develop RX-0201 for hepatocellular carcinoma
09.02.Novartis' Cosentyx label expanded to include scalp psoriasis
09.02.ViiV Healthcare sues Gilead over HIV drug patent infringement
08.02.FDA grants breakthrough therapy designation for GSK's meningitis B vaccine Bexsero
08.02.Janssen to co-develop Theravance's TD-1473 in $1bn deal
08.02.AstraZeneca's Brilinta shows benefits for heart attack patients in phase III trial
08.02.Old and discarded antibiotic compounds could become life-saving drugs